Illumina’s CEO Jacob Thaysen shares highlights from the company’s ‘Strategy Update' today and his vision for the business going forward
Jacob Thaysen covers Illumina’s business today, including the NovaSeq X platform, multiomics, clinical and pharma industry applications, and his case for getting Illumina back to financial growth in the years ahead.